Company news

Sensei Biotherapeutics, Inc. news in 2024

Sensei Biotherapeutics, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference

November 26, 2024

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

November 13, 2024

Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences

October 28, 2024

Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference

September 3, 2024

Sensei Biotherapeutics to Present at Upcoming Conferences

September 3, 2024

Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

August 5, 2024

Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference

May 29, 2024

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101

May 22, 2024

Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 8, 2024

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

April 23, 2024

Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference

April 8, 2024

Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment

April 3, 2024

Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium

March 21, 2024

Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences

March 5, 2024

Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights

February 27, 2024

Decks in 2024